Fact CheckerSign in

NCT06781372Not yet recruiting

Patient's Derived Organoids for Drug Screening in Glioblastoma

Development and Characterization of Patient's Derived Organoids as a Platform for the Screening of Novel Therapeutic Treatments for Glioblastoma Multiforme

Source: ClinicalTrials.gov · Last updated 13 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study will enroll patients suffering from glioblastoma, a malignant brain tumor. Intervention is intended as a laboratory intervention and not as a clinical intervention. In fact, tumor removed from patients' brains will be sent to a dedicated laboratory to obtain an "avatar" of the tumor, named patient-derived organoid (PDO). A number of experimental antitumor approaches will be studied on PDOs. Results of these experiments will be correlated to the prognosis of patients.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
7 Jan 2025
Start date
1 Apr 2025
Primary completion date
31 Jan 2028
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Diseases
Glioblastoma
NCT number
NCT06781372

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Apr 2025 to the primary completion date, 31 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous neoadjuvant chemotherapy or radiotherapy

Other illness

  • Brain surgery for tumor disease other than GBM

Age

  • Age \<18 years

Other

  • Needle biopsies
  • Inability to give informed consent

Who the study is looking for

  • adult patients undergoing resective neurosurgery for glioblastoma, IDH-wildtype

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.